BioMarin Pharmaceutical's total assets for Q4 2023 were $6.84B, an increase of 1.23% from the previous quarter. BMRN total liabilities were $1.89B for the fiscal quarter, a 1.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.